Literature DB >> 948236

Indicine-N-oxide: the antitumor principle of Heliotropium indicum.

M Kugelman, W C Liu, M Axelrod, T J McBride, K V Rao.   

Abstract

Extracts of Heliotropium indicum Linn. (Boraginaceae) showed significant activity in several experimental tumor systems. The active principle is isolated and shown to be the N-oxide of the alkaloid, indicine, previously isolated from this plant. Supporting structural data and anti-tumor data are provided.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 948236

Source DB:  PubMed          Journal:  Lloydia        ISSN： 0024-5461


  6 in total

1.  Pharmacokinetic study of indicine N-oxide in pediatric cancer patients.

Authors:  M M Ames; J S Miser; W A Smithson; P F Coccia; C S Hughes; D M Davis
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

2.  The Claim of Anti-Cataract Potential of Heliotropium indicum: A Myth or Reality?

Authors:  Samuel Kyei; George Asumeng Koffuor; Paul Ramkissoon; Clement Afari; Emmanuel Akomanin Asiamah
Journal:  Ophthalmol Ther       Date:  2015-11-23

3.  Studies on Wound Healing Activity of Heliotropium indicum Linn. Leaves on Rats.

Authors:  G K Dash; P N Murthy
Journal:  ISRN Pharmacol       Date:  2011-04-12

4.  Ethnopharmacological survey of different uses of seven medicinal plants from Mali, (West Africa) in the regions Doila, Kolokani and Siby.

Authors:  Adiaratou Togola; Drissa Diallo; Seydou Dembélé; Hilde Barsett; Berit Smestad Paulsen
Journal:  J Ethnobiol Ethnomed       Date:  2005-09-27       Impact factor: 2.733

5.  Nutritional value, micronutrient and antioxidant capacity of some green leafy vegetables commonly used by southern coastal people of Bangladesh.

Authors:  S M Neamul Kabir Zihad; Yashu Gupt; Shaikh J Uddin; Muhammad Torequl Islam; Md Rabiul Alam; Shahin Aziz; Mahmood Hossain; Jamil A Shilpi; Lutfun Nahar; Satyajit D Sarker
Journal:  Heliyon       Date:  2019-11-19

Review 6.  Heliotropium indicum L.: From Farm to a Source of Bioactive Compounds with Therapeutic Activity.

Authors:  Chandan Sarkar; Milon Mondal; Bilkis Khanom; Md Monir Hossain; Md Solayman Hossain; Antoni Sureda; Muhammad Torequl Islam; Miquel Martorell; Manoj Kumar; Javad Sharifi-Rad; Ahmed Al-Harrasi; Ahmed Al-Rawahi
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-01       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.